About N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide
N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide (PubChem CID 23800004) has the molecular formula C18H13BrN4OS2
and a molecular weight of 445.37 g/mol. Its IUPAC name is N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide.
Analyze N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide?
The IUPAC name of N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide (CID 23800004) is N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide.
What is the SMILES notation for N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide?
The canonical SMILES for N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide is O=C(CSc1nc2ccccc2n1-c1ccccc1)Nc1ncc(Br)s1.
What is the InChIKey of N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide?
The InChIKey is VUFNYULSGZANQJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H13BrN4OS2/c19-15-10-20-17(26-15)22-16(24)11-25-18-21-13-8-4-5-9-14(13)23(18)12-6-2-1-3-7-12/h1-10H,11H2,(H,20,22,24).
What are the key properties of N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide?
N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide has a molecular weight of 445.37 g/mol, XLogP of 4.98, 5 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-bromo-1,3-thiazol-2-yl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide is sourced from PubChem (CID 23800004), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).